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Non-bilayer structurePeptidyl-glycine-leucine-carboxyamide (PGLa), isolated from granular skin glands of Xenopus laevis, is
practically devoid of secondary structure in aqueous solution and in the presence of zwitterionic
phospholipids, when added exogenously, but adopts an α-helix in the presence of anionic lipids. The
peptide was shown to exhibit antifungal activity and to have antimicrobial activity towards both Gram-
negative and Gram-positive bacteria. As a broad variety of peptides is found in the secretions of amphibian
skin combinatorial treatment of PGLa and magainin 2 was studied showing enhanced activity by a
heterodimer formation. Thus production of mutually recognizing peptides seems to be an effective way in
nature to increase selective membrane activity. Biophysical studies on membrane mimics demonstrated that
PGLa can discriminate between different lipid species, preferentially interacting with negatively charged
lipids, which are major components of bacterial but not mammalian cell membranes. This emphasizes the
role of electrostatic interactions as a major determinant to trigger the afﬁnity of antimicrobial peptides
towards bacterial membranes. PGLa induced the formation of a quasi-interdigitated phase in phosphati-
dylglycerol bilayers below their chain melting transition, which is due to the creation of voids below the
peptide being aligned parallel to the membrane surface. In the ﬂuid phase of phosphatidylglycerol the
peptide inserts perpendicularly into the bilayer above a threshold concentration, which results in a
hydrophobic mismatch of the peptide length and bilayer core for lipids≤C16. This mismatch is compensated
by stretching of the acyl chains and in turn thickening of the bilayer demonstrating that membrane thinning
cannot be taken generally as the hallmark of pore formation by antimicrobial peptides. Furthermore, PGLa
was shown to affect membrane curvature strain of phosphatidylethanolamine, another main lipid
component of bacterial membranes, where a cubic phase coexists with the ﬂuid bilayer phase. Investigations
on living Escherichia coli showed distinct changes in cell envelope morphology, when treated with the
peptide. In a ﬁrst stage loss of surface stiffness and consequently of topographic features was observed,
followed in a second stage by permeabilization of the outer membrane and rupture of the inner
(cytoplasmic) membrane supposedly by the mechanism(s) derived from model studies.© 2009 Elsevier B.V. All rights reserved.Contents
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ll rights reserved.Nowadays, we face a world-wide re-emergence of infectious
diseases and a rapid increase in pathogenic bacteria that are multi-
resistant to commercially available antibiotics. Hence the World
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disease and published a comprehensive document “Global Strategy
for the Containment of Antimicrobial Resistance” suggesting some
guidance on the implementation of interventions such as improving
the use of antibiotics, enforcing regulations, strengthening health-
care systems and encouraging the development of novel antibiotics.
Latter is a pressing need, because the number of new antibiotics
markedly decreased within the last decades. However, new drugs
with similar structures relative to existing antibiotics will remain
highly vulnerable to bacterial resistance mechanisms and will have
only a limited life span. Therefore, alternative agents with novel
mechanisms of action have to be developed. One emerging strategy
is based on host defence peptides, which have evolved in nature to
contend with invaders as an active system of defence (see also
Zasloff this special issue).
This review focuses on one of the antimicrobial peptides found
in skin secretions of frogs, namely PGLa (peptidyl-glycine-leucine-
carboxyamide). In the ﬁrst part of the review it will be reported
about the discovery of this peptide and its biological activities. It
will be described, how this peptide acts synergistically with
magainin, another antimicrobial peptide component of frog, to
combat pathogenic fungi, which are one cause of the world-wide
decline of the population of this animal species. The potential of this
peptide to be used for the development of a novel antimicrobial
therapeutic will be also brieﬂy addressed. As this peptide act on the
cell membrane level a large extent of this review is devoted to
studies using membrane mimetic systems, which have shed light on
the mode of action of PGLa. It will be shown that the mechanism of
membrane perturbation strongly depends on the phospholipid
matrix and that PGLa is able to discriminate between different
lipid species. These biophysical studies suggest that the peptide is
capable of forming pores in lipid bilayers. However, it was also
shown that PGLa affects membrane properties such as curvature
strain and induces lipid–peptide domain formation owing to the
preferential interaction of the cationic peptide with the anionic
membrane lipids. Both perturbations may alter the environment of
membrane proteins leading to membrane dysfunction. The ﬁnal part
of the review deals with microscopy experiments on living Escher-
ichia coli cells showing that indeed membrane damage may be
considered as the mode of killing by PGLa.
1. Discovery and characterization of PGLa
The skin of frog is a rich source of peptides [1], which are present in
large quantities, in particular in the Xenopus species, as well as in
Bombina as outlined by Simmaco and co-authors as well as by Zasloff
within this special issue. A comprehensive analysis performed for the
South African clawed frog, Xenopus laevis [2] showed that major
components are peptidyl-glycine-leucine-carboxyamide or PGLa,
consisting of 21 amino acid residues, magainins (23 residues) and a
25 residue peptide derived from the xenopsin precursor, which differ
in their primary structure. The existence of PGLa was predicted
through screening of a c-DNA library for clones encoding the
precursor of caerulein by Kreil et al. [3], when searching in amphibian
skin secretions for peptides closely related to mammalian hormones
and neurotransmitters. The novel predicted peptide comprised 24
amino acids starting with tyrosine and ending with an amidated
leucine and thus was designated PYLa. In this study it was concluded
that this peptide can form a membrane-active amphipathic helix
similar to peptides with bacteriostatic, cytotoxic and/or lytic proper-
ties. The natural counterpart was isolated two years later from skin
secretion of X. laevis by the same group [4], which was very similar to
PYLa except for the absence of the ﬁrst three N-terminal amino acids
(Tyr-Val-Arg). This truncated peptide, corresponding to the amino
acids 39 to 59 of the precursor protein, can be generated by additional
processing at the single arginine residue, another proteolytic cleavagein addition to the predicted processing events. The peptide can
undergo further fragmentations producing at least eight different
peptides [5]. The most abundant fragments related to amino acids 1–
11 and 12–21, obtained through cleavage at the Gly-Lys site of PGLa.
The actual peptide was characterized by HPLC and mass spectroscopic
analysis [4,5] yielding the primary structure:
GMASKAGAIAGKIAKVALKAL-carboxyamide
now termed PGLa with a molecular weight of 1968.5. At neutral pH
this peptide, ultimately shown to be antimicrobial [6] has a positive
net charge of 5 because of the four lysine residues and the amino
group at the N-terminal glycine. Furthermore, the peptide possesses,
as does melittin, an amidated C-terminus, which supposedly
increases its resistance to proteases as shown for magainin [7]. PGLa
has little homology to other peptides found in the skin secretions of
X. laevis, but owing to the general similarities, it is often included in
the magainin family.
In aqueous solution, PGLa is less soluble than magainin 2a [8]. CD
spectra of the peptide dissolved in physiological buffer indicated that
the peptide is practically devoid of secondary structure at concentra-
tions below 1 mg/ml [9]. At higher peptide concentrations the
percentage of random structure decreased and of β-structure
increased. Additionally a small amount of α-helix was detected.
Similarly, IR experiments with PGLa in D2O solution showed at acidic
and neutral pD a maximum at 1643 cm−1, which is characteristic for
peptides with little or no well-deﬁned secondary structure [10].
Raman [8] and CD studies [11,12] also showed little regular structure
in aqueous solution at neutral pD for magainins. In contrast, Raman
data [8] obtained at low temperatures in saline solution at pH 7.4
indicated that PGLa formed reversibly a precipitate containing β-
sheet (63%) and reverse turn structure (21%). Jackson et al. [10]
explained this observation by the different experimental conditions,
which probably reﬂects aggregation of the peptide in the Raman
study. As peptide aggregation is often accompanied by intermole-
cular H-bonds, the formed intermolecular β-sheets may be mistaken
for intramolecular β-sheets.
2. Tissue distribution and biological activities of PGLa
The tissue distribution and cellular localization of PGLa and
peptides of the magainin family in X. laevis were early on studied.
Two genes from this family, magainin and PGLa, are expressed at high
level in the skin and throughout the gastrointestinal tract as well as in
the small intestine [13–16]. Initial studies on the biosynthesis of PGLa
demonstrated that it is located in the granular skin glands of X. laevis
and proceeds through a pathway that involves discrete morphological
rearrangements of the entire secretory compartment [13]. However,
the peptide was found not only being stored at high concentration in
the skin but being also abundant in the gastrointestinal system of the
frog [14]. The antimicrobial activity detected in extracts of stomach
tissue led to the puriﬁcation of nine antimicrobial peptides, shown to
undergo the same processing as their dermal counterparts. In the
gastric mucosa the peptides are stored in granular cells, which have a
spherical, syncytial multinucleated structure containing a cytoplasmic
space ﬁlled with dense rice-shaped granules [15]. This enteric
peptide-producing cell is strikingly similar both morphologically and
biochemically to the granular gland of the amphibian skin. Finally,
PGLa and magainin gene expression was also found in large,
eosinophilic granular cells of the X. laevis small intestine, which
share some common feature with the mammalian Paneth cell, a site of
expression of antimicrobial peptides [16]. Thus the biological activity
of PGLa was tested on a number of bacteria and fungi, but also on
viruses and human cells in order to gain information on the potential
of the peptide for therapeutic development and to understand ﬁrst
line defence mechanism.
Table 2
Spectrum of antimicrobial activity of the Xenopus granular gland peptides PGLa and
magainin 2 (Mag2).
Bacteria Species Minimal inhibitory
concentration [μg/ml]
PGLa Mag2
Gram-negative Escherichia coli 32a 64a
Pseudomonas aeruginosa 128a 128a
200–500b 50–100b
Gram-positive Staphylococcus aureus 64a 256a
50–100b N500b
Streptococcus pyogenes 10–50b 10–50b
a Data taken from Blazyk et al. [23].
b Data taken from Soravia et al. [6].
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against pathogens gained some major interest because of the world-
wide decline of the population of these animals. Pathogens associated
with the mass mortality of amphibians are the fungi, Batrachochy-
trium dendrobatidis and Basidiobolus ranarum, respectively, as well as
the bacterium Aeromonas hydrophila [17 and refs. therein]. A.
hydrophila is an opportunistic bacterium found on the skin and in
the digestive tracts of healthy amphibians, but capable to induce
diseases as shown for the South African clawed frog X. laevis and
American toad Bufo americanus. All these pathogens can infect the
skin of the animals and thus it was of interest to study the protective
effect of antimicrobial peptides isolated from the granular glands of
skin. Six peptides originating from three different frogs were tested:
PGLa, caerulein precursor fragment (CPF), magainin 1 and 2 from X.
laevis, ranalexin from the bullfrog Rana catesbeiana and dermaseptin
from Phyllomedusa sauvagii [17]. All peptides were able to kill or
inhibit the growth of both fungi but showed different efﬁcacy. At least
one peptide of each species was effective against both fungi at a
concentration of about 10–20 μM. PGLa was highly active against B.
ranarum inhibiting growth at a concentration of 3.1 μM. However,
higher peptide concentrations were necessary to prevent signiﬁcant
growth at later time points (after 48 h) and to completely eliminate
growth during 4 days of culture, a pattern also observed with other
peptides. All six peptides, however, were ineffective against the
bacterium A. hydrophila. Because these peptides are released in the
skin together, an equimolar mixture of PGLa and magainin 2 was
tested at concentration as high as 50 μM each, but failed to inhibit
growth of the bacterium. In contrast, a synergistic effect was observed
on the fungi, e.g. complete growth inhibition of B. ranarum at a
concentration of 0.4 μM of each peptide was achieved. This suggests
that antimicrobial peptides in the skin of amphibians can act as a ﬁrst
line of defence against fungi.
Antifungal activity of cationic amphiphilic peptides is also of
interest because of the rise in number of immunocompromised
patients, which has led to an increase in mucosal and systemic fungal
infections, and concomitantly to the development of antifungal drug
resistance owing to the prophylactic use of antifungal agents [18]. A
number of pathogenic Candida strains as well as Cryptococcus
neoformans were shown to be highly susceptible to PGLa with IC50-
values lower than amphotericin B [17] (Table 1). Only Candida
glabrata was less sensitive to cationic antifungal agents like PGLa
most likely due to the regulation of the expression of drug efﬂux
pumps, which affects negatively the efﬁcacy and intracellular
accumulation of cationic molecules [19]. In some pilot experiments,
PGLa was added to dilution series of amphotericin B, ﬂuconazole, and
5-ﬂucytosine to assess the effects of the peptide on the minimal
inhibitory concentration of these agents [20]. Addition of PGLa to
amphotericin B showed a synergistic effect against several Aspergillus,
Candida and Cryptococcus strains, while no enhanced activity was
found in combination with ﬂuconazole or 5-ﬂucytosine. Aspergillus
fumigatus being resistant to amphotericin B was shown to be also
sensitive to sole PGLa [17]. Nevertheless, Helmerhorst et al. [21]
pointed out that the candicidal activity of cationic peptides mayTable 1
Killing activities of PGLa and amphotericin B against pathogenic yeasts.
Strain IC50 [μM]a
PGLa Amphotericin B
Candida pseudotropicalis 311 1.3±0.7 7.2±1.9
Candida albicans 315 1.0±0.3 2.2±0.18
Candida krusei 355 0.8±0.3 N70
Candida parapsilonis 356 0.8±0.4 6.0±1.0
Candida glabrata 359 8.5±1.0 1.9±0.2
Cryptococcus neoformans 316 0.4±0.2 1.0±0.1
a Data are taken from Helmerhorst et al. [44] and represent means±standard
deviations from two independent experiments.strongly depend on the ionic strength of the test media. Therefore, the
authors compared growth inhibition of Candida albicans and lysis of
human erythrocytes at low and high ionic strength for several
peptides including peptides of the magainin family. Subtle differences
of biological activities between these peptides were only detectable at
low ionic strength, while all peptides showed weak haemolytic and
antifungal activity at physiological buffer conditions. PGLa, when
tested under low salt concentration (buffer supplemented with
297 mM glucose to prevent osmotic lysis of erythrocytes) was highly
active against both human erythrocytes (HC50=0.6 μM) and C.
albicans (IC50=1.1 μM) and thus is poorly selective. In contrast,
magainin 2 exhibited a reasonable selectivity also at low ionic
strength.
Antimicrobial peptides have also been strongly considered for the
development of novel antibiotics owing to their strong growth
inhibitory and microbicidial activity against bacteria in in vitro assays.
Table 2 summarizes the antimicrobial activity of PGLa and magainin 2
on some representative bacterial species of Gram-negative and Gram-
positive bacteria demonstrating that both peptides exhibit a similar
spectrum and range of minimal inhibitory concentration (MIC). In a
more recent study a lower MIC-value of 8 μg/ml was reported for E.
coli and growth inhibition of the Gram-positive bacteria B. subtilis and
M. luteus was observed in the same concentration range (MIC=4 μg/
ml) [22]. Therefore, PGLa has served as a template for synthetic
peptides, which exhibited improved antimicrobial activity, but also
increased potential towards haemolytic activity [e.g. 23,24]. A
development towards a therapeutic agent requires however that
these peptides have low cytotoxicity towards the host cell. Comparing
the haemolytic and antimicrobial activity of a peptide yields an
estimate for the cell selectivity of the investigated peptides as
described above. Sometimes it is difﬁcult to compare the reported
haemolytic activity of a given peptide owing to different experimental
protocols, which often differ regarding cell density. For PGLa e.g. 7%
hemolysis at 1000 μg/ml peptide [6] and 18% hemolysis at 500 μg/ml
peptide were reported [24].
As mentioned earlier the broad variety of peptides found in the
secretions of amphibian skin has suggested to investigate whether
combinatorial treatment can also enhance antimicrobial activity. In
fact, the equimolar mixture of PGLa and magainin 2 showed a
signiﬁcant improvement of antimicrobial activity in comparison to the
sole peptides [25], but also a marked functional synergism in tumor
cells [26] and model membranes [8,26,27,28]. Cross-linking experi-
ments suggested the formation of a heterodimer composed of parallel
helices [29]. This was conﬁrmed by a chemically ﬁxed heterodimer by
adding a Gly-Gly-Cys group to each peptide linked via a disulﬁde bond
[25]. This hybrid peptide showed membrane permeabilizing activity
against negatively charged liposomes and antimicrobial activity
similar to the physical mixture of PGLa and magainin 2 (Table 3). In
addition, this synthetic heterodimer showed enhanced activity
against zwitterionic liposomes and human erythrocytes as compared
to the physical mixture and the individual peptides (Table 3). These
Table 3
Comparison of antimicrobial activities and hemolysis of PGLa and magainin 2 (Mag2)
with their equimolar mixture and hybrid peptide, respectively.
L18W-PGLa Mag2 Mixture Hybrida
Minimal inhibitory concentration [μM]b
Escherichia coli 20 20 2.5 1.25
Staphylococcus epidermidis 5 20 2.5 5
% hemolysisc
Human erythrocytes 2.0 1.2 13.4 77.9
a Concentrations are expressed as concentrations reduced to monomers.
b Data taken from Nishida et al.[25], the Try-analog (L18W-PGLa) showing the same
activity as PGLa.
c After 3 h incubation of erythrocytes (1% v/v) with 15.6 μM (L18W-PGLa or Mag2) or
31.2 μM (mixture and hybrid) peptides.
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peptides seems to be an effective way in nature to increase selective
membrane activity [25].
3. Interaction of PGLa with membrane mimetic systems
3.1. Lipid discrimination and membrane selectivity of PGLa
As addressed brieﬂy in the previous chapter antimicrobial peptides
can exhibit selective activity towards bacterial and mammalian cells,
which is thought to be strongly related to the different membrane
architecture and lipid composition of eukaryotic and bacterial cell
membranes [30,31 and refs. therein]. The general differences in the
lipid composition between these cell membranes relates to the
increased amount of negatively charged lipids in the outer membrane
leaﬂet of bacterial cell membranes, which serves as a primary target of
the cationic peptides. Thus, zwitterionic lipids such as PC and
sphingomyelin (SM) are characteristic for mammalian cell mem-
branes, while the negatively charged lipids PG and diPG or cardiolipin
are main components that comprise – together with PE – bacterial
cytoplasmic membranes. Moreover, the cell envelope of Gram-
negative bacteria is a complex structure consisting of the cytoplasmic
or inner membrane and a unique outer membrane with an interven-
ing layer of peptidoglycan (Fig. 1). The outer membrane has aFig. 1. Schematic representation of the membrane architecture of Gram-negative bacteria co
(LPS) and phospholipids, and a cytoplasmic or inner membrane. Phosphatidylglycerol is the
and Gram-positive bacteria. Latter has only a cytoplasmic membrane. Predominant lipid tardistinctive, highly asymmetric composition with anionic lipopolysac-
charides (LPS or endotoxin) located exclusively in its outer leaﬂet,
which is of particular interest in respect of interaction of cationic
antimicrobial peptides with these bacteria (see Shai and Mangoni
within this issue). In contrast, Gram-positive bacteria have a simple
lipid bilayer membrane protected by a lipoteichoic acid layer, which
confers the bacterial surface a negative charge too. Although recent
studies showed that the lipid net charge is not the decisive factor
determining the activity and membrane-perturbing mechanism(s) of
antimicrobial peptides [32], electrostatic interaction will govern
adsorption of these peptides on the membrane surface [31]. In
addition, upon interaction with the negatively charged lipid head-
group conformational changes can be induced, which transform
antimicrobial peptides that are unstructured in aqueous solution into
a membrane-active, mostly α-helical conformation (see below).
Thereby, induction of the active conformation upon interaction with
the target membrane represents one possibility to control membrane
selectivity.
Early biophysical studies on membrane model systems clearly
demonstrated that indeed a number of antimicrobial peptides can
distinguish between different lipid species, which led to the concept of
lipid discrimination [9,30,33,34]. For example, preferential interaction
with negatively charged phospholipids was reported for the β-sheet
peptides such as tachyplesin from horseshoe crab [35], human
neutrophil peptide [34,36] or protegrin-1 from porcine leukocytes
[37]. Furthermore, magainin killed more effectively Gram-negative
bacteria containing an inner membrane with higher amounts of
phosphatidylglycerol [38], which emphasizes the role of electrostatic
interactions as a major determinant to trigger the afﬁnity of
antimicrobial peptides towards bacterial membranes.
The same general observation was made for PGLa. Biophysical
studies on the interaction of PGLa with liposomes consisting of
dipalmitoylphosphatidylcholine (DPPC) and egg sphingomyelin, a
simple mimic for mammalian cell membranes, and of the acidic
dipalmitoylphosphatidylglycerol (DPPG), representative of bacterial
membranes, demonstrated that PGLa also discriminates between
these lipids [9]. Microcalorimetric experiments showed that PGLa had
no effects on the thermotropic phase behavior of liposomes composed
of the choline phosphatides, while separation of a distinct peptide-
rich domainwas observed for phosphatidylglycerol liposomes (Fig. 2).nsisting of an outer membrane with an asymmetric distribution of lipopolysaccharides
most abundant negatively charged phospholipid species found in both Gram-negative
gets of antimicrobial peptides are indicated.
Fig. 2. Thermogram of DPPG in the presence of PGLa at a lipid/peptide molar ratio of 50.
Lipid and peptide were co-dispersed in 10 mM NaPi, pH 7.4. Experimental data (solid
line), ﬁtted data (broken line), individual components of peptide poor and enriched
domains (dotted line).
Fig. 3.Models of lipid organization in a monolayer with and without PGLa based on X-
ray reﬂectivity and grazing incidence diffraction data. Molecular mixing of PGLa and
DSPGwith perturbed hydrocarbon chain order as well as formation of separate domains
of PGLa and DSPC is shown.
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narrow transition owing to the peptide perturbed lipid domains was
found at 41 °C, which enthalpy increased upon increasing concentra-
tions of PGLa. The assumption of a peptide-enriched domain was
supported by X-ray diffraction experiments, which indicated that
PGLa penetrates into the hydrophobic core of the bilayer inducing an
untilting of the hydrocarbon chains as observed in the gel phase of the
pure lipid. The nature of the peptide induced lipid domains was
revealed only recently [39] and will be described in the following
chapter.
Discrimination between neutral and negatively charged lipid
species is further supported by monolayer studies, where PGLa was
found tomix with PG at a molecular level, but to form separate islands
in zwitterionic PC monolayers [40,41]. Structural details of the
phospholipid monolayers in the presence and absence of PGLa were
obtained from Synchrotron experiments (Fig. 3) showing that the
peptide strongly perturbed the lipid acyl chain order of distearoylpho-
sphatidylglycerol (DSPG) [40]. An increase of bending rigidity of the
DSPG monolayer was observed, while adding PGLa to a DSPC
monolayer resulted in a reduction of the overall bending rigidity
[41]. One can envisage that changes of membrane bending rigidity
owing to peptide insertion into the lipid bilayer may result in domain
and/or defect structures, which will affect membrane integrity.
Surface pressure/potential-area isotherms showed that the anti-
microbial frog skin peptide, PGLa, formed a very stable monolayer
with 2 PGLa molecules per kinetic unit and a collapse pressure of
∼22 mN/m, which is below the lateral pressure of biological
membranes [40]. X-ray grazing incidence diffraction indicated that
the peptide-dimer formation did not lead to self-aggregation with
subsequent crystallite formation. The scattering length density proﬁle
derived from X-ray reﬂectivity measurements yield information on
the PGLa monolayer that protrudes into the air phase by about 0.8 nm
suggesting that the peptide is aligned parallel to the air/water
interface [40]. In bilayers different orientations of PGLa were reported
depending on peptide concentration, phase state and synergistic
interactions with magainin-2, ranging from a surface aligned mono-
meric state, via tilted dimers, to an upright inserted state [e.g.
28,39,42,45,48], which are described in detail by Ulrich and coworkers
within this special issue. The process of PGLa binding and insertion
was studied thermodynamically using PC/PG mixtures (3/1 mol/
mol) showing an exothermic binding of the peptide to the membrane
surface, followed by a slower endothermic process above a threshold
concentration [43]. Latter was related to pore formation, which was
also deduced from other biophysical approaches [27,39].
Information on the secondary structure of PGLa upon interaction
with lipids was obtained by various spectroscopic techniques. CD
spectra of PGLa in the presence of the zwitterionic phosphatidylcho-
line and sphingomyelin, closely resembled the features of thespectrum gained for the peptide in buffer solution indicating that
the peptide adopts a random structure [9]. A different behavior was
observed in the presence of DPPG, where two deﬁned minima at 210
and 222 nmwere detected [9], characteristic for anα-helical structure
in agreement with IR-data [10]. A helical structure to about 60% was
calculated, which suggests an α-helical C-terminal and a more or less
unstructured N-terminal part. This would be consistent with the
primary structure of PGLa, from where it can be inferred that several
Gly residues, known as helix breakers, are located in the more
hydrophobic N-terminal part of the sequence, while the remainder
consists predominantly of helix stabilizing amino acids, namely Ala,
Leu and Lys. This was conﬁrmed by calculating a helix probability
proﬁle, which shows a marked increase in helicity for the C-terminal
half in the presence of anionic lipids [9] and is in agreement with
multidimensional solution NMR spectroscopy data showing that PGLa
is helical between residues 6 and 21, when associated with detergent
micelles [46]. This study also revealed that the amino-terminal
residues are highly mobile and that the ﬂuctuations of backbone
sites decrease from Ala at position 6 towards the C-terminus with Ala
at position 20 being essentially rigid. If PGLa, however, is not added
exogenously but co-dispersed from a dry lipid/peptide ﬁlm, and if
there is no excess of water present in the sample into which the
cationic peptide can escape, it will form an α-helix even in neutral
phosphatidylcholine [47] and phosphatidylethanolamine bilayers
[68]. A helical wheel projection of PGLa indicates the lateral
amphipathic character of the peptide clustering the positively charged
Lys residues on one side of the helix (Fig. 4). It should be noted
however that induction of an α-helix is not necessarily sufﬁcient to
induce antimicrobial activity. For example, an alanine substitution
analog of PGLa, where the bulky Ile residues, supposed to act as
membrane anchor, were replaced by Ala, exhibited even a slightly
higher content of α-helix in the presence of bacteria mimetic vesicles,
but did not show any appreciable antimicrobial activity against E. coli
Fig. 4.α-helical structure of PGLa assuming a full helix (coordinates kindly provided by A. Ulrich, Forschungszentrum Karlsruhe, Germany) and helical wheel presentation. Position of
lysine residues and amidated C-terminal (amide is not shown) as well as length and diameter of the helix are indicated in the panel.
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the lower hydrophobic moment per residue and total hydrophobicity
of the alanine substitution analog as compared to PGLa affecting
membrane partitioning.
3.2. PGLa has distinct effects on the bilayer thickness of PG
Recently it was demonstrated, how profoundly the mechanism of
membrane disruption depends on the nature of the membrane lipid
composition, varying not only with lipid headgroup charge but also
with hydrocarbon chain length [32,50]. Based on systematic studies
on LL-37 a phase diagram for PG and PC showing different lipid/
peptide arrangements as a function of hydrocarbon chain length andFig. 5. Schematic representation of structural changes induced by PGLa, when incorporated i
surface inducing an averaged thinning of the bilayer, while in the ﬂuid phase (TNTm) it inse
small-angle scattering curves of DPPG in the gel and ﬂuid phase in the absence and presence
blue line: DPPG/PGLa). The circle indicates the deviation of model ﬁts assuming no and thepeptide concentration was established. Further, it had been suggested
that this phase diagram is generally applicable to membrane-active
peptides localized parallel to the membrane surface, as similar effects
were observed for PGLa and melittin [50].
A follow-up study using X-ray diffraction, solid-state 2H-NMR,
differential scanning calorimetry, and dilatometry, investigated in
detail the structural changes occurring in PG bilayers by addition of
PGLa as a function of the acyl chain length (C14 to C18) [39]. The
effects of the peptide varied strongly with the phase state of the lipid
in a concentration dependent manner. In the gel phase, PGLa induced
a quasi-interdigitated phase (Fig. 5), which coexists in various
proportions with the original lamellar gel phase, manifested as two
separate phase transition, as had been observed in initial DSC studiesn DPPG bilayers. In the lamellar gel phase (TbTm) PGLa aligns parallel to the membrane
rts perpendicular to the membrane plane inducing a thickening of the bilayer. Typical
of PGLa are presented. Solid lines show the model ﬁts to the data (red line: pure DPPG,
presence of a quasi-interdigitated phase. Lipid/peptide molar ratio is 25.
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the quasi-interdigitated phase into the ﬂuid Lα phase. The presence of
this structure was most prominent for the longest chain PG studied,
i.e. DSPG. The occurrence of a quasi-interdigitated structure was also
reported for LL-37 for these PGs [50]. While PGLa had no profound
effect on DPPC, LL-37 led to a disintegration of the lamellar
organization of this zwitterionic lipid into disk-like micelles. However,
interdigitationwas observed for the longer-chain C18 and C20 PC. This
dual behavior of LL-37 was attributed to a balance between
electrostatic interactions reﬂected in different penetration depths of
the peptide and hydrocarbon chain length as outlined below [50].
These observations clearly indicate that there is a tight coupling
between the peptide properties and those of the lipid bilayer.
Induction of interdigitation of hydrocarbon chains in the gel phase
can be understood in terms of the “free volume” (void) model, as
described earlier for small amphiphilic molecules such as e.g. alcohols,
anesthetics or surfactants [51,52]. It has been suggested that the
lateral expansion of a phospholipid bilayer caused by the intercalation
of amphiphilic molecules between phospholipid molecules and the
mismatch between their hydrocarbon chain lengths results in the
creation of voids in the hydrophobic region of the bilayer. In analogy,
when peptides get embedded into the gel phase bilayer at the water/
lipid interface aligned parallel to themembrane surface, it will create a
void below the peptide. The extent of void formation will depend on
the size and penetration depth of the peptide. It was shown that
cationic peptides penetrate less deeply into the hydrophobic core of
anionic as compared to neutral bilayers [53]. Formation of free volume
within the hydrophobic core of the bilayer is energetically unfavour-
able and hence the system will rearrange in a way to maximize the
hydrophobic interactions. Elimination of the free volume can be
achieved via increased trans-gauche isomerisation of the hydrocarbon
chains of the neighboring lipids or by moving the methyl ends of the
opposing lipid monolayer close to the peptide, thereby generating the
interdigitated lipid structure. Both will result in a decrease of the
bilayer thickness though to various degree. A compensation of the free
volume by an elastic monolayer deformation is not possible due to the
high bending rigidity in the gel phase [54]. An increased acyl chain
disorder was observed in DPPG/PGLa mixtures both fromwide-angle
X-ray diffraction and NMR data arising from phospholipids at the
borderlines of the defect zones between the coexisting gel phases.
This phenomenon was not observed for DSPG indicating that PGLa
very effectively transforms the bilayer into an interdigitated phase,
which is consistent with the larger void induced in the hydrophobic
core of the bilayer and the propensity of DSPG to form an
interdigitated phase even in the absence of the peptide [55].
In the biologically more relevant ﬂuid phase PGLa forms pores in
PG membranes above a critical threshold concentration [39]. Thus the
authors addressed the question, how this translates into structural
changes of the ﬂuid phase, as previous experiments had shown that
LL-37 leads to a thinning of PC and PG bilayers [32]. Membrane
thinning has been also observed in several other lipid/peptide
interaction studies [56 and refs. therein]. In the ﬂuid phase the bilayer
may respond elastically to a peptide embedded in the water/lipid
interface, because the bending rigidity is about one order of
magnitude lower than in the gel phase, which can lead to a local
membrane deformation and thinning on the global average over the
membrane upon insertion of the peptides [56–58]. In contrast to these
ﬁndings PGLa induced a membrane thickening of DMPG and DPPG
bilayers, while no changes in the overall bilayer structure were
detected for DSPG [39]. Latter observation was explained by
considering the length of the α-helix of PGLa and the thickness of
the lipid bilayer core showing that PGLa remarkably ﬁts into the
hydrophobic core of DSPG, when inserted perpendicular to the bilayer
plane. However, in case of DPPG the peptide cannot be accommodated
with its full length and thus the lipid responds to the insertion of the
peptide by stretching of the hydrocarbon chains leading to an increaseof membrane thickness by about 2 Å (Fig. 5). Such a behavior was
reported earlier for PC bilayers in the presence of hydrophobic model
peptides of various length with N- and C-terminal interface anchors
[59]. In the case of DMPG, the increase in bilayer thickness was less
pronounced than for DPPG due to tilting of the peptidewith respect to
the bilayer normal, which has been observed in DMPC/DMPG [47].
These results demonstrate that membrane thinning cannot be taken
generally as the hallmark of pore formation by antimicrobial peptides.
3.3. Cubic phase formation — effect on membrane curvature
Microorganisms such as e.g. E. coli or Acholeplasma laidlawii have
been shown to precisely regulate their lipid composition in a narrow
window close to a bilayer to non-bilayer phase boundary, thereby
conferring upon these membranes a degree of non-lamellar structure
forming propensity [60–62]. The presence of non-lamellar phase
forming lipids such as PE, cardiolipin or monoglucosyldiacylglycerol
leads to an increase in the lateral pressure in the center of the bilayer
because of their cone-shapedmolecular geometry (smaller headgroup
area as compared to the cross sectional area at the methyl region of
the acyl chains). This in turn results in a bilayer state, where the desire
for monolayer curvature is physically frustrated, which is in contrast
to lamellar phase forming lipids such as PG or choline phospholipids
exhibiting a cylindrical molecular shape and therefore a uniform
lateral pressure throughout the hydrocarbon chain region of the
bilayer. Thus, it was proposed that antimicrobial peptides may lower
the bilayer to non-bilayer phase boundary leading to membrane
rupture in case of bacteria with high content of non-lamellar phase
forming lipids [31].
Formation of non-bilayer structures may be understood qualita-
tively in terms of this lateral pressure proﬁle [63] balancing the
repulsive and attractive interactions between the individual lipid
molecules within the compound of the lipid bilayer. Insertion of a
membrane-active compound affects this balance and may lead to a
long-range effect in form of a globally curved membrane [64]. Such
effects are particularly pronounced, if lipids exhibit a propensity to
negative curvature such as phosphatidylethanolamines, which make
up more than 80% of the total phospholipids of E. coli [30]. This amino
phospholipid can adopt non-bilayer structures, such as the inverted
hexagonal (HII) and cubic (QII) phases [65,66], whereby the Lα-HII
phase transition temperature depends on the acyl chain composition
being around 75 °C for palmitoyloleoyl-PE (POPE) [65,67]. A recent
differential scanning calorimetry and small-angle X-ray diffraction
study showed that pure POPE partially converts into cubic phases
upon cooling from the HII phase [68]. Thereby, two QII phases of space
group Pn3m and Im3m, respectively, coexist with the Lα phase and
vanish upon the transition into the Lβ gel phase (Fig. 6). Adding PGLa
(4 mol%) to POPE caused an increase of the bilayer to non-bilayer
phase transition temperature by about 9 °C and a signiﬁcant
broadening of the transition range [68]. Small-angle X-ray diffraction
showed that a pure Lα phase exists up to 70 °C. Upon further heating
the intensity of the Bragg peak being characteristic for the lamellar
phase continuously decreased on account of peaks that can be
ascribed to a cubic phase belonging to the space group Pn3m with a
lattice spacing of 131 Å at 90 °C, which coexists with the ﬂuid Lα phase.
Upon cooling the QII phases vanished and at 30 °C only the ﬂuid Lα
phase was observed (Fig. 6).
In the presence of melittin (4 mol%) the Lα-HII transition was
abolished and only a bilayer structure was observed in the
temperature range studied, which was explained by electrostatic
repulsion due to the charged peptide [68]. Seemingly this does not
play a role for PGLa, which has the same net charge as melittin, but
exhibited a strongly reduced bilayer separation as compared to
melittin. This is most likely due to shielding of the positive charges of
PGLa by insertion into the lipid bilayer supported by the observation
that PGLa signiﬁcantly affected the chain melting transition of POPE.
Fig. 6. Structural phase transitions of pure POPE (left) and in the presence of PGLa (right) as a function of temperature. A contour plot of the small-angle X-ray diffraction data
obtained upon heating and cooling is shown. Phase assignment is indicated in the panel (lamellar gel phase, Lβ, ﬂuid lamellar phase, Lα, inverted hexagonal phase, HII and cubic
phases, QII). The insert shows the water channels within the unit cell of Pn3m (adapted from http://www.msri.org/about/sgp/jim/geom/surface/global/skeletal/index.html).
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membranes above a critical threshold concentration [47] and perme-
ability experiments that suggested pore formation [27] it was
proposed that PGLa is present in the PE bilayer as lipid/peptide
pores as well as inserted as monomers [68]. It was suggested that the
monomeric fraction of PGLa is responsible for the increase of
transition temperature by stabilization of a negative Gaussian
curvature modulus but facilitates at higher temperature the formation
of the QII phases similar to fusion peptides by creating local defects.
The complete stabilization of the Lα phase, i.e. the fraction which did
not convert into a cubic phase, was attributed to be due to lipid/PGLa
pores, as the formation of a fusion pore in such a case would require
that the lipid/peptide pores ﬁrst come into registry and then
promote trans-membrane contact. In the absence of any driving
force for this mechanism the authors concluded that such a scenario
remains highly unlikely.
A different behavior was observed for gramicidin S, which led to a
complete transformation of the ﬂuid Lα phase into QII phases [68]. The
capability of gramicidin S to strongly promote cubic phase formation
was shown earlier using lipid extracts from E. coli and A. laidlawii [69].
It was proposed that the formation of the bicontinous cubic lipid
phases is due to the limited ﬂexibility of the β-turn of gramicidin S as
well as to the clustered location of the ornithine side chains that
strongly promotes negative curvature. A signiﬁcant increase in
monolayer curvature stress is likely to be of major importance for
the formation of non-lamellar structures [33]. Promotion of such
structures in PE model systems has been also shown for other
antimicrobial peptides [31 and refs. therein]. Huang and coworkers
[56 and refs. therein] proposed thatmembrane thinning, related to the
elastic response of the lipid bilayer, is compensated by an increase of
the hydrophobic cross sectional area of the lipid acyl chains. In case of
PE this lateral expansion would further enhance the existing
mismatch between the cross sectional areas of the headgroup and
hydrocarbon side chains, inducing the lipid monolayer to curl.
Finally, it should be mentioned that some antimicrobial peptides
such as nisin [70] or a 17 β-amino acid oligomer [71] can stabilize the
inverse hexagonal phase. In case of nisin this was explained in analogy
to hydrophobic molecules such as squalene [72] being due to insertion
of the large hydrophobic section of nisin (segments 1–19), which will
lead to an increase of the hydrophobic volume in the bilayer interior.
This in turn will promote negative curvature and hence formation ofinverted non-lamellar structures. Similarly it was argued that owing to
the penetration depth of a 17 β-amino acid oligomer HII-structures
were facilitated by expanding the regions of the bilayer below the
pivotal plane more than regions close to the interface. Again this will
result in an increase of negative curvature strain [71].
The different packing properties may have also implications for
membrane function. For example, it has been suggested that the high
lateral hydrocarbon chain pressure, exhibited by such lipids, controls
the conformation of integral membrane proteins. In accordance with
this assumption are observations that non-lamellar lipids are often
required for functional reconstitution of membrane proteins [73] and
that PE is found in protein rich membrane domains [74]. Therefore,
one may speculate that antimicrobial peptides that affect the lateral
hydrocarbon chain pressure upon insertion may lead to conforma-
tional changes of integral membrane proteins and hence to impair-
ment of membrane function.
4. Images on the impact of PGLa on living E. coli cells
The inﬂuence of PGLa on living E. coli was investigated by imaging
the cells with atomic force microscopy [75,76] showing distinct
changes in cell envelope morphology, when treated with the peptide.
AFM images obtained under physiological aqueous conditions [75],
where the mica was pre-treated with polylysine for better immobi-
lization of the bacteria, revealed that PGLa induces formation of
micelles within 5 min of treatment accompanied by a morphological
change of the bacteria from a rod-shape to a ﬂuid ﬂattened structure.
After 30 min only the lower parts of cellular membrane was left
attached to the substrate, which had lengths and widths that
correspond to the size of the ﬁxed bacterial cell. Another important
observation relates to the complete removal of the pilar structure
attached to the bacteria indicating that the peptide leads to disruption
of the outer membrane. However, under these conditions the
resolution of the images were low most likely due to the deformation
of the bacteria during scanning and therefore observation of bacteria
in air was also performed giving a better resolution than in water.
These experiments demonstrated that interaction of PGLa with E.
coli strongly reduced the cell stiffness and increased the surface
roughness [75,76], which was also observed in the presence of
magainin 2a and the cytolytic peptide melittin [76]. In general the
roughness of the outer membrane increased with the increase in
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effect. This morphological change may be caused by exposure of the
peptidoglycan layer and/or peptide incorporation into the LPS-
containing outer membrane causing a “crumbling” effect due to an
increase of the lateral monolayer area. Incorporation of cationic
antimicrobial peptides into the LPS layer was also suggested in earlier
studies [e.g. 77,78]. Such a damage to the outer membranemay in turn
enhance the penetration of peptides to the highly sensitive inner
membrane. Peptide transfer across the outer membrane to the
periplasmic space, which involves the direct binding of the cationic
peptides to LPS, was proposed by Hancock and termed the so-called
self-promoted uptake system [79]. The packing of LPS molecules,
which is essential for the permeability control and membrane
integrity, strongly depends on divalent cations [80]. Interaction of
the cationic peptides may displace Mg2+ ions from the LPS layer of the
cell surface leading to insertion of the peptide into the outer
membrane cross binding the negative charges of LPS as has been
shown for example for the antimicrobial peptide polymyxin B [81,82].
In fact, addition of 10 mMMg2+ ions prior to PGLa treatment partially
inhibited the effects of the peptide [75]. Under these experimental
conditions PGLa showed less damage to E. coli cells owing to the
competition for the negative charges present in LPS molecules.
Interestingly, bacteria treated with the chelating agent EDTA did
neither show substantial damage of the membrane nor measurable
differences in stiffness as compared to the untreated bacteria.
Furthermore, the treated bacteria retained their overall morphology.
The effect simply seems to be restricted to a roughening of the outer
membrane. This observation is in agreement with the suggestion that
EDTA removes Mg2+ ions from the LPS layer of E. coli increasing the
electrostatic repulsion within the LPS molecules [84]. The observed
roughness can then be explained by an increase in the area of the LPS
monolayer and partial loss of LPS without formation of holes or
discontinuities. Although EDTA increases the permeability of the outer
membrane, treatment of E. coli cells with this chelating agent during
short periods is not lethal, but can be used to introduce macro-
molecules through the outer membrane without signiﬁcant loss in
viability [81,83]. The fact that E. coli retained its rigidity and
morphology during the EDTA treatment suggested that it obviously
does not affect the peptidoglycan layer, which serves as a strong
mechanical structure as well as diffusion barrier.
AFM images obtained in the presence of magainin 2a and melittin
showed similar but in some aspects different effects on E. coli cells as
compared to PGLa [76]. These experiments, performed below and
above their LC50-value, gave additional interesting details upon the
action of membrane-active peptides on bacterial cells. Images
obtained below LC50 demonstrated that all three peptides tested
induced the most damage at the apical ends of the cell. This is of
interest, because results from experiments with a cardiolipin sensitive
dye demonstrated that cardiolipin domains were located at the apical
ends of E. coli inner membrane [73]. Therefore it is tempting to
speculate that these peptides may preferentially interact with the
negatively charged cardiolipin.
In fact, it has been shown that the antimicrobial peptide protegrin-
1 can distinguish between different negatively charged lipids [85].
This is further supported by recent observation on a synthetic
antimicrobial peptide, which induced demixing of a cardiolipin and
phosphatidylglycerol mixture [86]. In this respect it is also interesting
to note that leakage experiments showed that in the case of rabbit
defensin, cardiolipin seems to be essential for creating lesions as no
leakage was observed for liposomes composed of phosphatidylgly-
cerol and -ethanolamine [36]. On the other hand, phase segregation in
this model system, which is a mimic of the bacterial cytoplasmic
membrane, was reported for PGLa [33] and also observed for other
antimicrobial peptides such as HNP-2 [32,34] or alpha/beta anti-
microbial peptides [87] emphasizing the preferential interaction of
the cationic peptides with negatively charged lipids. Formation andsegregation of lipid domains may inﬂuence membrane properties and
in turn membrane function by creating defect zones of increased
permeability and membrane domains of changed ﬂuidity.
Melittin was most effective in cell rupture, as can be expected
from its low MIC and non-selective membranolytic activity. Already
below LC50 melittin induced the formation of grooves and pore-like
lesions as well as the collapse of the cell structure at the apical ends,
with one end being more elastic [76]. In addition, a large amount of
released vesicles or peptide aggregates, which may include LPS and
membrane-associated compounds, was clearly visible. Above LC50 in
addition to a collapse of the apical ends, the outer membrane
showed severe damage with large lesions. Furthermore, a very
pronounced leakage of cytosolic ﬂuid was observed clearly indicat-
ing the damage of the inner membrane. Below LC50 magainin 2a
induced blebbing (surface-bound vesiculation) of the LPS-rich outer
membrane as well as some lesions in agreement with an earlier
electron microscopy study [88]. Above LC50 it almost completely
destructed the bacterial cell, where vesiculation, deep lesions as
well as a collapse of the apical and the septal region of the cell were
observed. A possible exposure of parts of the more rigid peptido-
glycan layer was also suggested. The effects observed for PGLa
below LC50 were intermediate between the changes induced by
melittin and magainin 2a, while above LC50 PGLa had similar but
less visual effects as compared to magainin 2a.
In summary, the ﬁrst stage of action can be characterized by the
loss of surface stiffness and consequent loss of bacteria topographic
features owing to the incorporation of the peptides into the LPS
layer. In a second stage after permeabilization of the outer
membrane the peptides also interact with the inner (cytoplasmic)
membrane ﬁnally leading to total cell rupture as suggested by the
loss of cytoplasmic material. Biophysical studies have shown that a
number of relevant parameters have to be considered to understand
the effect of antimicrobial peptides on membranes and thus caution
has to be taken to derive the molecular mechanism(s) from model
studies. Nevertheless, the studies described within this review
suggest that disruption of the inner membrane by PGLa will most
likely occur by pore formation but changes in membrane ﬂuidity
due to lipid segregation and membrane curvature strain may be
considered as well.
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